Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moyuru Yamada

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of colon cancer with multiple liver metastases showing a long-term response following first-line therapy]Hirokazu Sawami, Masaru Murata, Hidekazu Takahashi, et al.
Oncology Letters|October 2, 2023
Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinomaMoyuru Yamada, Koji Tanaka, Kenichi Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of locally advanced rectal carcinoma treated with preoperative chemoradiotherapy resulting in pathologically complete response]Shinsuke Katsuyama, Masaru Murata, Nobuo Tanaka, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of colon cancer with multiple liver metastases showing a long-term response following first-line therapy]Hirokazu Sawami, Masaru Murata, Hidekazu Takahashi, et al.
Oncology Letters|October 2, 2023
Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinomaMoyuru Yamada, Koji Tanaka, Kenichi Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of locally advanced rectal carcinoma treated with preoperative chemoradiotherapy resulting in pathologically complete response]Shinsuke Katsuyama, Masaru Murata, Nobuo Tanaka, et al.
Pageof 2